Use this URL to cite or link to this record in EThOS:
Title: Chromosomal engineering to produce a model of human 5q-syndrome
Author: Holmes, L. R.
Awarding Body: University of Cambridge
Current Institution: University of Cambridge
Date of Award: 2006
Availability of Full Text:
Full text unavailable from EThOS.
Please contact the current institution’s library for further details.
Initial chromosomal engineering has been undertaken on the syntenic region of mouse chromosome 11. Chromosomal deletions were generated using Cre-loxP technology.  A primary loxP site was inserted at a determined anchor point, the sparc gene, present within the syntenic region identified on chromosome 11. Deletions were then created in ES cells following the insertion of a second loxP site into the same copy of chromosome 11, either using a random integration strategy or a defined targeting methodology, and the expression of Cre recombinase. A defined deletion of 150 kb was successfully generated by targeting a second loxP site to the glral gene which represented one end of the delineated critical region identified in humans. In addition, a series of nested deletions were generated successfully, varying in size from a few kb to over 5 Mb, from the sparc gene anchor point by the random integration of a second loxP site. Three mouse strains have been generated that are heterozygous for a deletion, although none have demonstrated a significant disruption to haematopoiesis. To complement the deletion strategy, a gene targeting approach was used to disrupt a candidate tumour suppressor gene present in the syntenic region identified on chromosome 11. The gene selected was fat2, a member of the cadherin gene family and homologue of the Drosophila fat tumour suppressor gene. Fat2-deficient mice were generated and analysis thus far has demonstrated the fat2 gene is not critical for normal haematopoiesis in 6 month old animals. Mice generated in this study have provided novel reagents with which to investigate the mechanisms of 5q- syndrome. Their use in conjunction with other reagents developed in the laboratory should prove useful in providing insight into the cellular and molecular controls that contribute to this disease.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID:  DOI: Not available